Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$1,443,311
+$81,047 QoQ
Shares Held
5,683
+2.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#2,633
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Old Port Advisors holds $21,158,060 across 12 Drug Manufacturers - General names. JNJ ranks #8 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
69,539 | $3,645,234 | |
| 2 | NVS |
Novartis AG
|
21,266 | $3,332,807 | |
| 3 | PFE |
Pfizer Inc
|
114,101 | $2,747,552 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
36,348 | $2,094,371 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
16,332 | $2,063,384 | |
| 6 | SNY |
Sanofi
|
48,080 | $2,051,092 | |
| 7 | LLY |
ELI LILLY & Co
|
1,253 | $1,502,885 | |
| 8 | JNJ |
Johnson & Johnson
This page
|
5,683 | $1,443,311 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,443,311 | 5,683 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $1,362,264 | 5,573 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $1,053,582 | 5,091 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $929,325 | 5,012 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $763,597 | 4,999 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $847,608 | 5,111 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $747,974 | 5,172 | Shares | Sole | 2025-01-02 | |
| 2024-09-30 | $865,076 | 5,338 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $775,232 | 5,304 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $822,746 | 5,201 | Shares | Sole | 2024-06-26 | |
| 2023-12-31 | $857,054 | 5,468 | Shares | Sole | 2024-06-26 | |
| 2023-09-30 | $870,798 | 5,591 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $889,855 | 5,741 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $1,032,519 | 5,845 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $964,150 | 5,902 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $1,022,812 | 5,762 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $1,031,478 | 5,820 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $1,005,378 | 5,877 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $978,528 | 6,059 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $987,781 | 5,996 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $1,017,819 | 6,193 | Shares | Sole | 2021-04-08 | |
| 2020-12-31 | $960,018 | 6,100 | Shares | Sole | 2021-01-08 | |
| 2020-09-30 | $928,117 | 6,234 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $873,593 | 6,212 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $797,663 | 6,083 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||